nicorandil has been researched along with nicardipine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Akahane, K; Chiba, S; Furukawa, Y; Ogiwara, Y | 1 |
| Hirabayashi, M; Ikegaki, I; Matsusawa, M; Nakanishi, T; Nishimura, M; Takahashi, H; Yoshimura, M | 1 |
| Fukuo, K; Imanaka, S; Kim, S; Kitano, S; Koh, E; Miyashita, Y; Morimoto, S; Morita, R; Ogihara, T | 1 |
| Berdeaux, A; Dubois-Randé, JL; Ghaleh, B; Giudicelli, JF; Hittinger, L | 1 |
| Kato, H; Kurihara, J; Ochiai, N | 1 |
| Bernal, JM; Cubeddu, RJ; Don, CW; Kiernan, GD; Kiernan, TJ; Ruggiero, NJ; Witzke, C; Yan, BP | 1 |
1 review(s) available for nicorandil and nicardipine
| Article | Year |
|---|---|
The no-reflow phenomenon in the coronary circulation.
Topics: Adenosine; Animals; Coronary Circulation; Diltiazem; Humans; Nicardipine; Nicorandil; Nitroprusside; No-Reflow Phenomenon; Prostheses and Implants; Vasodilator Agents; Verapamil | 2009 |
6 other study(ies) available for nicorandil and nicardipine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
K+ channel blocking and anti-muscarinic effects of a novel piperazine derivative, INO 2628, on the isolated dog atrium.
Topics: Adenosine; Animals; Atrial Function; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Guanidines; Heart Atria; Myocardial Contraction; Niacinamide; Nicardipine; Nicorandil; Pinacidil; Piperazines; Potassium Channels; Time Factors | 1991 |
Intracerebroventricular injections of endothelin increase arterial pressure in conscious rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Brain; Endothelins; Guanidines; Injections, Intraventricular; Male; Niacinamide; Nicardipine; Nicorandil; Pinacidil; Quinazolines; Rats; Rats, Inbred Strains; Vasodilator Agents | 1990 |
Nicorandil is a potent dilator of endothelin-induced vascular contraction.
Topics: Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Endothelins; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicardipine; Nicorandil; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilator Agents; Verapamil | 1990 |
Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
Topics: Acetylcholine; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Guanidines; Heart Rate; Niacinamide; Nicardipine; Nicorandil; Nitroglycerin; Pinacidil; Vascular Resistance; Vasodilator Agents | 1995 |
Protection by nicorandil against the dysfunction of the central vagal baroreflex system following transient global cerebral ischaemia in dogs.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cerebrovascular Circulation; Dogs; Female; Heart Rate; Ischemic Attack, Transient; Male; Niacinamide; Nicardipine; Nicorandil; Nitroglycerin; Pressoreceptors; Reflex; Stereotaxic Techniques; Vagus Nerve; Vasodilator Agents | 1993 |